Apicore

Apicore is a private, revenue-generating contract development and manufacturing organization (CDMO) focused on the generic drug sector. The company leverages its expertise in complex chemistry to offer a vertically integrated service model, from early-stage research and process optimization to commercial manufacturing of APIs and intermediates. Its strategic location in a major pharmaceutical hub and focus on cost-effective production for off-patent drugs position it as a key partner for companies seeking to bring generic therapeutics to market. Apicore's business model is built on long-term client partnerships and a diversified portfolio of chemical processes.

Integrated chemical development and manufacturing platform for APIs and intermediates, encompassing process R&D, scale-up, cGMP production, and analytical services.

Apicore competes in the fragmented small molecule API CDMO space against large global players (e.g., Lonza, Cambrex), other US-focused CDMOs, and lower-cost manufacturers in India and China. Its differentiation lies in its integrated service model and focus on complex chemistry for the generic sector.